Homepage
Author:
Fedora Pharmaceuticals, Inc.
Posted Date:
June 10, 2026
Fedora Pharmaceuticals Expands Scientific Advisory Board with Appointment of Drs. Michael Dudley, Keith Micetich, and Jürgen Bulitta
Fedora Pharmaceuticals, Inc.
June 10, 2026
Fedora Pharmaceuticals Presentations at 2026 ESCMID Highlight Safety and Potent Bactericidal Activity of FPI-2119
Fedora Pharmaceuticals, Inc.
April 20, 2026
Fedora Pharmaceuticals Showcasing Antibiotic Candidate at 2026 European Society of Clinical Microbiology and Infectious Diseases Congress
Fedora Pharmaceuticals, Inc.
April 9, 2026
Fedora Pharmaceuticals Highlights Efficacy of Novel Antibiotic, FPI-2119, against Antimicrobial-resistant Gram-negative Bacteria at the 2026 IMARI Conference
Fedora Pharmaceuticals, Inc.
January 29, 2026
